| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/08/2006 | CN1742719A Bilobanoate oral-cavity disintegrating tablet and preparation method |
| 03/08/2006 | CN1742718A Method for preparing rifamicina injecta |
| 03/08/2006 | CN1742717A Liquid medicine containing lucidril and preparing method |
| 03/08/2006 | CN1742716A Diclofenac sodium dropping pill and preparing method |
| 03/08/2006 | CN1742715A Diclofenac diethylamine gel agent |
| 03/08/2006 | CN1742714A Water-dispersive nano-grade ibuprofen injecta and preparing method |
| 03/08/2006 | CN1742713A Method for preparing sodium ferulate sterilized raw-material medicine |
| 03/08/2006 | CN1742712A Menantine hydrochloride soft capsule and preparing method |
| 03/08/2006 | CN1742711A Menantine hydrochloride effervescent tablet and preparing method thereof |
| 03/08/2006 | CN1742710A Use of bromoisovanillin in preparing anti-cancer and/or anti-radiation, chemical therapy sensitivity-enhancing medicines |
| 03/08/2006 | CN1742709A Method for extracting high-content solanesol extract by liquid-liquid two-phase method |
| 03/08/2006 | CN1742708A Transdermal administration pressure-sensitive gel composite substrate |
| 03/08/2006 | CN1742706A Water-soluble medicine degradable polymer microcapsule injecta and preparing method |
| 03/08/2006 | CN1742623A Hyaluronic acid phospholipid composition and preparing method thereof |
| 03/08/2006 | CN1742588A Method for purifying melatomin in milk product and detection method therefor |
| 03/08/2006 | CN1244698C Expression of recombination SARS virus gene in polymorphic Hansen yeast and its use |
| 03/08/2006 | CN1244688C Microbe and process for preparing pravastatin sodium |
| 03/08/2006 | CN1244592C Antisense nucleic acid having inhibiting leukemia cell telomerase activity and its application |
| 03/08/2006 | CN1244591C mRNA antisense nucleic acid with inhibited VEGF expression and its application |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244583C Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives, its synthesizing method and application in producing anticancer preparation |
| 03/08/2006 | CN1244582C Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 03/08/2006 | CN1244581C Method for producing anticholinergic agent substitute bromide |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244579C Synthesis of 2-oxazolidone derivate by one still process |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244577C 4-phenyl-peiperazinyl,-piperidinyl and -tetrahydropyridyl derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/08/2006 | CN1244574C Method for preparing water-soluble soybean aglycon and its applications |
| 03/08/2006 | CN1244573C Benzofuran category compound, its preparing method and usage |
| 03/08/2006 | CN1244569C C-10 position taxane derivative and its medicine composition |
| 03/08/2006 | CN1244563C Dibenzo [b,f] azepine intermediates |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244558C 1,2-hydrindene or indoline derivative |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/08/2006 | CN1244375C Human liver regeneration related protein and its application |
| 03/08/2006 | CN1244374C Pharmaceutical composition for treating rheumatism, rheumatoid arthritis and limb pains, and its preparation method |
| 03/08/2006 | CN1244371C Chinese medicinal liquid for treating tinea on manus and pedes |
| 03/08/2006 | CN1244367C Chinese medicine oral liquid for curing epilepsy sickness |
| 03/08/2006 | CN1244365C External use of Chinese herb medicinal mixture for treating mumps |
| 03/08/2006 | CN1244361C Medicinal composition for curing oral and throat diseases and its preparing method and use |
| 03/08/2006 | CN1244358C Exterior coating medicine for relieving toothache |
| 03/08/2006 | CN1244355C Series medicament of zanthoxylum bungeanum seed kernel oil and pseudo-ginseng total saponin and preparing process thereof |
| 03/08/2006 | CN1244351C Compound powder preparation for curing gynecopathy and its preparation method |
| 03/08/2006 | CN1244340C Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process |
| 03/08/2006 | CN1244337C Natural medicated health food for preventing and treating diabetes and cardiac vascular diseases induced thereby |
| 03/08/2006 | CN1244336C Infantile antipyretic and preparing method and quality controlling method thereof |
| 03/08/2006 | CN1244333C Rhodiola root powdery injection and its preparation |
| 03/08/2006 | CN1244330C Application of golden buckwheat rhizome in the preparing process of medicine for treating respiratory syncytial virus infected disease |
| 03/08/2006 | CN1244329C Use of anti-pregnant-hormone for preparing medicine for inhibiting accelerated endometrial maturation of female mammals |
| 03/08/2006 | CN1244328C Medicine for preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (NOS) |
| 03/08/2006 | CN1244327C Thebaic analgesic with controllable release of active content |
| 03/08/2006 | CN1244326C Fatigue-resistant drug composition |
| 03/08/2006 | CN1244325C Application of anethole trithione in pharmacy |
| 03/08/2006 | CN1244324C Reforming effect of arginine to recessive harm of skin tissue of diabetes |
| 03/08/2006 | CN1244323C Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 03/08/2006 | CN1244322C Use of inhibitors of sodium-hydrogen exchanging pump for production of medicine for treatment of disorders which are caused by protozoa |
| 03/08/2006 | CN1244321C Gastric 5-fluorouracil double slow release tablet of float and stay type for treating gastric cancer |
| 03/08/2006 | CN1244320C Nose spray agent |
| 03/08/2006 | CN1244281C Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 03/07/2006 | US7009069 Intermediates for use in retinoid synthesis |
| 03/07/2006 | US7009067 Hexa-citrated phytate and process of preparation thereof |
| 03/07/2006 | US7009061 Diterpene compounds |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009057 Method for obtaining pioglitazone as an antidiabetic agent |
| 03/07/2006 | US7009056 Glaucoma; multiple sclerosis |
| 03/07/2006 | US7009054 Quinolines and uses thereof |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009052 such as 1-methyl-2-oxo-4-trifluoromethyl-1,2-dihydroquinoline-6-sulfonic acid phenylamide for use as androgen antagonists |
| 03/07/2006 | US7009051 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity |
| 03/07/2006 | US7009050 5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 03/07/2006 | US7009049 Syntheses of quinazolinones |
| 03/07/2006 | US7008963 Urushiol induced contact dermatitis solution |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008961 Composition and method for treating carcinoma |
| 03/07/2006 | US7008960 Causing liquefaction of the vitreous humor in the eye of a human or veterinary patient by administering urea or urea derivative such as hydroxyurea or thiourea; use with nonsteroidal anti-inflammatory drugs (NSAIDS) |
| 03/07/2006 | US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 03/07/2006 | US7008958 Such as 2-bromo-6-methoxy-5-(5-oxazolyl)-1H-indole-3-carboxaldehyde for treating disorders associated with inosine monophosphate dehydrogenase (IMPDH); immunosuppressants, anti-cancer agents |
| 03/07/2006 | US7008957 6-amino-5-oxo--hexahydropyrrolo[2,1-b]thiazole-3-carbonitrile compounds of given formula; for the treatment of metabohlic disorders such as type 2 diabetes |
| 03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
| 03/07/2006 | US7008955 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists |
| 03/07/2006 | US7008954 method of use to treat chronic graft versus host disease, autoimmune diseases, and other specified diseases by administering a tricyclic compound of given structure which includes a pyridyl ring, two phenyl rings and either an amino or oxy group |
| 03/07/2006 | US7008953 3-((mono- or di-fluoro-benzimidazol-2-yl))-5-(4-methyl-5-(ethylaminomethyl)pyrid-3-yl)indazole; inhibitors of cyclin dependent kinases(CDK) for use treating cancer and other proliferative disorders such as retinopathy, rheumatoid arthritis |
| 03/07/2006 | US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/07/2006 | US7008951 Such as asthma or chronic obstructive pulmonary disease; mixture of a corticoid such as budesonide, fluticasone propionate or mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or its salt |
| 03/07/2006 | US7008950 For example 3-(4-Isopropylphenyl)-5-(4-methoxybenzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran and its synthesis; suppress cell toxicities caused by beta-amyloid protein, protect nerve cells |
| 03/07/2006 | US7008949 Antiinflammatory agents; antihistamines; Alzheimer's disease; anticholesterol agents; cardiovascular disorders; inflammatory bowel disorders; antitumor agents; antidiabetic agents; brain disorders; multiple sclerosis |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2006 | US7008947 Use to treat anxiety, depression, a sleep disorder such as primary insomnia, circadian rhythm sleep disorder, dyssomnia NOS, nightmare disorder, or attention deficit disorder |
| 03/07/2006 | US7008946 CCR5 antagonists useful for treating AIDS |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008944 Treating obsessive compulsive disorder, panic attacks, sexual disorders, eating disorders, obesity, drug abuse and ethanol or cocaine dependence; anxiolytic agents |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008942 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/07/2006 | US7008940 1,6,7,8-tetrahydro-2,2,4,5-tetramethyl-1-(4-methylphenyl)-2H-furo[3,2-e]indole for example; inhibiting lipoperoxide production (antioxidant); treating restenosis after percutaneous transluminal coronary angioplasty; Alzheimer's disease |
| 03/07/2006 | US7008939 Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008937 Porphyrins and metalloporphyrins for inhibiting heme iron uptake |